Functional Outcome Scales in Traumatic Brain Injury: A Comparison of the Glasgow Outcome Scale (Extended) and the Functional Status Examination

Abstract

Clinical trials aimed at developing therapies for traumatic brain injury (TBI) require outcome measures that are reliable, validated, and easily administered. The most widely used of these measures, the Glasgow Outcome Scale (GOS) and the GOS-Extended (GOS-E), have been criticized as suffering from ceiling effects. In an attempt to develop a more useful and dynamic outcome measure, the Functional Status Examination (FSE) was developed, which grades outcome across 10 functional domains. The FSE has been demonstrated to be reliable and sensitive in monitoring recovery after TBI. This manuscript compares FSE with GOS-E in a cohort of patients with a wide range of injury severities. 177 individuals who survived at least 6 months after TBI were studied. The FSE and GOS-E were administered 6-12 months after injury. FSE and GOS-E scores correlated well with each other. FSE scores were distributed throughout the range, indicating that ceiling and floor effects were not present. Physiologic measures of injury severity (Glasgow Coma Score [GCS]) did not correlate with anatomic measures (Abbreviated Injury Scale [AIS] and Injury Severity Score [ISS]). GCS correlated weakly with both outcome measures, but AIS/ISS did not. We conclude that FSE and GOS-E are reliable outcome measures for TBI survivors, and FSE may offer some advantages over GOS-E due its ability to provide a more detailed description of deficits. The majority of the variance in outcome is not accounted for by currently available measures of injury severity.

Cerebral Atrophy after Traumatic White Matter Injury: Correlation with Acute Neuroimaging and Outcome

“…Dikmen et al (2001Dikmen et al ( , 2003 demonstrated that FSE is more sensitive to recovery at 1-6 months compared to GOS. Our previous study also showed that FSE and GOS-E scores correlated well with each other (r ¼ À0.83), while FSE is a more sensitive outcome measurement (Hudak et al, 2005).…”

The Role of D-Dimer, Fibrinogen and C-Reactive Protein as Plasma Biomarkers in Acute Ischemic Stroke

“…Elevated D-dimer level has also been shown to relate to early clinical progression [5], stroke subtypes [6], and infarction volume [7]. Some studies have suggested that D-dimer can be seen as an outcome predictor in ischemic stroke and an indicator of severity of traumatic brain injury [8].…”

Endotracheal intubation and outcome in high-risk patients with acute myocardial infarction undergoing primary angioplasty

“…Our study has some important limitations: first, it is a retrospective analysis and is therefore subject to the limitations of such analyses. Due to its retrospective design, a weakness of our study is a deficiency in accurately collecting some history and clinical information like formal neurologic or functional severity scores [29][30][31][32] and the number of the patients who receiving mild-induced hypothermia, which has been demonstrated to have a strong beneficial impact on long-term survival and neurological status in the setting of outof-hospital cardiac arrest [33]. Secondly, the nonrandomized nature of the comparison may have resulted into bias: for this reason, propensity score matching further enhanced the comparability of the patients.…”